Our ESG Investor Event focused on our company’s long-term strategies related to access to health, employees, environmental sustainability, and ethics & values
Carmen Villar, vice president, social business innovation, always defended the underdog – now she leads a team solely focused on reducing health disparities
Fiona Marshall, MSD’s head of discovery sciences & translational medicine, on overcoming challenges to advance the discovery and development of future therapies
Dr. Anthony Fauci, director of NIAID, sits down with MSD’s Dr. Julie Gerberding to reflect on early HIV innovations and the challenges that still remain in ending the epidemic
In this Teal Talks episode, leaders discuss how the cinema, restaurant and cruise industries are poised for a comeback in the era of COVID-19 vaccinations
Fiona Marshall, MSD's senior vice president, Discovery, Preclinical & Translational Medicine, joins the ranks of one of the U.K.’s most distinguished scientific organizations
Jennifer Zachary, executive vice president and general counsel, who also leads safety, security and the environment, on our effort to help reduce the impacts of climate change
In our first Teal Talks episode, we discuss how the COVID-19 pandemic has shined a light on mental health and sparked a movement to change the way we work
The Anti-Defamation League awards Ken for his commitment to corporate responsibility and for his conviction that companies should be driven by purpose, not profits
A conversation with MSD Chief Patient Officer Julie Gerberding, M.D., M.P.H., about her early work caring for people with HIV and AIDS, and the parallels of the AIDS and COVID-19 pandemics
